JANUARY 2021: Oncology

Industry News Round-up

What’s new in oncology this January? We’ve rounded up information on the use of cancer microbiomes in tumors, an inhibitor drug combination for a rare form of cancer, and new clues to prostate cancer.

January 13, 2021 / Duke

Biomedical engineers have devised an algorithm to remove contaminated microbial genetic information from The Cancer Genome Atlas (TCGA). With a clearer picture of the microbiota living in various organs in both healthy and cancerous states, researchers will now be able to find new biomarkers of disease and better understand how numerous cancers affect the human body.

January 14, 2021 / UNH 

Researchers took the novel approach of targeting specific cell proteins that control DNA information using inhibitors, or drugs, that were effective in reducing the growth of the Waldenström macroglobulinemia cancer cells and when combined with a third drug were even more successful in killing the WM cancer cells which could lead to more treatment options.

January 15, 2021 / Flinders

New research has identified a new mechanism in which prostate cancer cells can ‘switch’ character and become resistant to therapy. These findings are an important development in unraveling how an aggressive subtype of prostate cancer, neuroendocrine prostate cancer (NEPC), develops after hormonal therapies.


Download PharPoint’s oncology experience overview

[contact-form-7 id=”9108″]